Consano Bio, Inc.

New Filing
CIK: 0001981285·Biotechnology·DELAWARE·Filed: Mar 20, 2026
Total Offering

$48,858,795

Amount Sold

$34,824,466

Investors

28

First Sale

Mar 6, 2026

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2024
Non-Accredited Investors
No

Related Persons

NameRole
Andrew Hall
Related Person
Jennifer Schmitke
Related Person
Doug Vander Weide
Related Person
Christopher Centeno
Related Person
Bill Abbington
Related Person
Jerome Adams
Related Person
Michael Pede
Related Person
Joe Schiesl
Related Person
John Conway
Related Person

Company

CONSANO BIOLOGICS, LLC

100 SUMMIT DRIVE

BURLINGTON, MA, 01803

617-798-4559

SEC Filing

0001981285-26-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free